首页 > 产品目录 > 免疫学 > 抗体 > 一抗 > Phospho-Erk1 / Erk2 (Thr 202)

Phospho-Erk1 / Erk2 (Thr 202)

Phospho-Erk1 / Erk2 (Thr 202)

产品编号 :
英文名称 :
中文名称 :
品牌 :
包装规格 交货周期 质量标准 目录价 会员专享价 数量
50ul 现货2-3天 原装正品
- +
100ul 现货2-3天 原装正品
- +
20ul 现货2-3天 原装正品
- +
基础信息
存储条件
产品详情
Product Profile
Product NamePhospho-Erk1 / Erk2 (Thr 202)
Antibody TypePrimary Antibodies
Antigen AliasERK 1 antibody ERK 2 antibody ERK-2 antibody ERK1 antibody erk1/2 antibody ERK2 antibody ERT1 antibody ERT2 antibody Extracellular signal regulated kinase 1 antibody Extracellular signal-regulated kinase 2 antibody MAP kinase 1 antibody MAP kinase 2 antibody MAP kinase isoform p42 antibody MAP kinase isoform p44 antibody MAPK 1 antibody MAPK 2 antibody MAPK 3 antibody Mapk1 antibody MAPK2 antibody MAPK3 antibody Mitogen-activated protein kinase 1 antibody Mitogen-activated protein kinase 2 antibody MK01_HUMAN antibody p38 antibody p40 antibody p41 antibody p42-MAPK antibody PRKM 2 antibody
Product descriptionThe activation of signal transduction pathways by growth factors, hormones and neurotransmitters is mediated through two closely related MAP kinases, p44 and p42, designated extracellular-signal related kinase 1 (ERK 1) and ERK 2, respectively (1–3). ERK proteins are regulated by dual phosphorylation at Tyrosine 204 and 187 and Threonine 177 and 160 residues mapping within a characteristic Thr-Glu-Tyr motif (4,5). Phosphorylation at both the Threonine 202 and Tyrosine 204 residues of ERK1 and Threonine 185 and Tyrosine 187 residues of ERK2 is required for full enzymatic activation (6). The structural consequences of dual-phosphorylation in the ERK2 include active site closure, alignment of key catalytic residues that interact with ATP, and remodeling of the activation loop (6). In response to activation, MAP kinases phosphorylate downstream components on serine and threonine (4,5). Upstream MAP kinase regulators include MAP kinase kinase (MEK), MEK kinase and Raf-1 (5). The ERK family has three additional members: ERK 3, ERK 5 and ERK 6 (7,8).
ImmunogenA short amino acid sequence containing phosphorylated Thr 202 of ERK 1/2 of human origin
Modificationp-Thr 202
Key Feature
ClonalityPolyclonal
IsotypeIgG
Host SpeciesRabbit
Tested ApplicationsWBIPIFIHC-P

WB:1:100-1:1,000
IP:1-2 μg per 100-500 μg of total protein (1 ml of cell lysate)
IF:1:50-1:500
IHC:1:50-1:500
Species ReactivityHumanMouseRat
Concentration1mg/ml
Target Information
Alternative NamesERK 1 antibody ERK 2 antibody ERK-2 antibody ERK1 antibody erk1/2 antibody ERK2 antibody ERT1 antibody ERT2 antibody Extracellular signal regulated kinase 1 antibody Extracellular signal-regulated kinase 2 antibody MAP kinase 1 antibody MAP kinase 2 antibody MAP kinase isoform p42 antibody MAP kinase isoform p44 antibody MAPK 1 antibody MAPK 2 antibody MAPK 3 antibody Mapk1 antibody MAPK2 antibody MAPK3 antibody Mitogen-activated protein kinase 1 antibody Mitogen-activated protein kinase 2 antibody MK01_HUMAN antibody p38 antibody p40 antibody p41 antibody p42-MAPK antibody PRKM 2 antibody
Molecular Weight(MW)p-ERK 1:44 kDa p-ERK 2: 42 kDa
Cellular LocalizationCytoplasm, Nucleus
Database Links
SwissProt IDP27361
Application

Application

Fig2: B.Immunoperoxidase staining of formalin-fixed, paraffin-embedded human breast carcinoma tissue showing nuclear and cytoplasmic staining.

Application

Fig2: B.Immunoperoxidase staining of formalin-fixed, paraffin-embedded human breast carcinoma tissue showing nuclear and cytoplasmic staining.
Positive ControlHela, human breast carcinoma tissue.
Application NotesWB:1:100-1:1,000
IP:1-2 μg per 100-500 μg of total protein (1 ml of cell lysate)
IF:1:50-1:500
IHC:1:50-1:500
Additional Information
FormLiquid
Storage InstructionsStore at +4℃
Storage Buffer1*TBS (pH7.4), 1%BSA, 40%Glycerol. Preservative: 0.05% Sodium Azide.


相关文献

抱歉,暂无相关文献

浏览记录

抱歉,暂无浏览记录